Therapeutic potential of natural compounds for treatment of chronic obstructive pulmonary disease: Current status and future perspective

被引:1
作者
Sahu, Sanjeev Kumar [1 ]
Rain, Musarraf [1 ]
Vyas, Manish [1 ]
机构
[1] Lovely Profess Univ, Sch Pharmaceut Sci, Jalandhar 144411, Punjab, India
来源
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY REPORTS | 2024年 / 11卷
关键词
Chronic obstructive pulmonary disease; Oxidative stress; Reactive oxygen species; Genetic factors; Alpha-1 antitrypsin deficiency; Mitochondria dysfunction; Natural compounds; CIGARETTE-SMOKE; INFLAMMATION; EXTRACT; PATHOGENESIS; EMPHYSEMA;
D O I
10.1016/j.ejmcr.2024.100159
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Chronic obstructive pulmonary disease (COPD) is a lung disease which is the third most common cause of premature death globally. Inhaling dangerous gases, cigarette smoking, and exposure to pollution are the main factors contributing to the development of COPD. These factors may harm lung tissue and create COPD causes. Increased synthesis of inflammatory mediators and proteases because of cigarette smoking exposure to transcriptional factors. Dysfunction of mitochondria essential part to lead and development of several human illnesses, such as chronic obstructive pulmonary disease. Alpha-1 antitrypsin deficiency boosts neutrophil elastase activity, which promotes tissue deterioration and emphysema (particularly in smokers because cigarette smoke also boosts protease activity). In this review, we discussed all these factors and summarized the conventional drug currently present for the treatment of COPD. In addition, we also focused on various natural compounds categorized under the flavonoids, polyphenols, alkaloids, glycosides and marine compounds which were reported for the effective treatment of COPD.
引用
收藏
页数:10
相关论文
共 50 条
[41]   The Potential Important Role of Mitochondrial Rieske Iron-Sulfur Protein as a Novel Therapeutic Target for Pulmonary Hypertension in Chronic Obstructive Pulmonary Disease [J].
Truong, Lillian ;
Zheng, Yun-Min ;
Wang, Yong-Xiao .
BIOMEDICINES, 2022, 10 (05)
[42]   Potential role of leukotriene modifiers in the treatment of chronic obstructive pulmonary disease [J].
Usery, Justin B. ;
Self, Timothy H. ;
Muthiah, Muthiah P. ;
Finch, Christopher K. .
PHARMACOTHERAPY, 2008, 28 (09) :1183-1187
[43]   Altered amino acid metabolism in chronic obstructive pulmonary disease: new therapeutic perspective? [J].
Engelen, MPKJ ;
Schols, AMWJ .
CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE, 2003, 6 (01) :73-78
[44]   Current views in chronic obstructive pulmonary disease pathogenesis and management [J].
Alfahad, Ahmed J. ;
Alzaydi, Mai M. ;
Aldossary, Ahmad M. ;
Alshehri, Abdullah A. ;
Almughem, Fahad A. ;
Zaidan, Nada M. ;
Tawfik, Essam A. .
SAUDI PHARMACEUTICAL JOURNAL, 2021, 29 (12) :1361-1373
[45]   Developments in drugs for the treatment of chronic obstructive pulmonary disease [J].
Mui, Tammy S. Y. ;
Man, S. F. Paul ;
Sin, Don D. .
EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2008, 4 (03) :365-377
[46]   Chronic obstructive pulmonary disease and emerging ER stress-related therapeutic targets [J].
Yeap, Jia Wen ;
Ali, Irfhan Ali Hyder ;
Ibrahim, Baharudin ;
Tan, Mei Lan .
PULMONARY PHARMACOLOGY & THERAPEUTICS, 2023, 81
[47]   Phosphodiesterase 4 inhibitors for the treatment of chronic obstructive pulmonary disease: a review of current and developing drugs [J].
Mulhall, Aaron M. ;
Droege, Christopher A. ;
Ernst, Neil E. ;
Panos, Ralph J. ;
Zafar, Muhammad A. .
EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2015, 24 (12) :1597-1611
[48]   Chronic obstructive pulmonary disease: Histopathology, inflammation and potential therapies [J].
Molfino, Nestor A. ;
Jeffery, Peter K. .
PULMONARY PHARMACOLOGY & THERAPEUTICS, 2007, 20 (05) :462-472
[49]   Chronic obstructive pulmonary disease: role of matrix metalloproteases and future challenges of drug therapy [J].
Srivastava, Punit K. ;
Dastidar, Sunanda G. ;
Ray, Abhijit .
EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2007, 16 (07) :1069-1078
[50]   Clonal Hematopoiesis of Indeterminate Potential Is Associated with Current Smoking Status and History of Exacerbation in Patients with Chronic Obstructive Pulmonary Disease [J].
Lee, Jung-Kyu ;
An, Hongyul ;
Koh, Youngil ;
Lee, Chang-Hoon .
TUBERCULOSIS AND RESPIRATORY DISEASES, 2024, 87 (03) :309-318